Source: Pulse2.0

Deep Genomics: Deep Genomics Closes $180 Million In Series C Funding

Deep Genomics announced recently that they have closed a $180 million Series C financing round. These are the details. The post Deep Genomics Closes $180 Million In Series C Funding appeared first on Pulse 2.0.

Read full article »

Deep Genomics's Competitors | Deep Genomics's News | Deep Genomics's Financials

Followers on Owler

192

Est. Annual Revenue

$5.0-25M

Est. Employees

100-250

CEO

Brian O’Callaghan

CEO Approval Rating

82/100

Deep Genomics is a Canada-based biopharmaceutical company that researches and develops AI-driven RNA therapeutics for the treatment of genetic conditions.